Stratifying ALS Patients into Clinically Relevant Subpopulations to Develop Targeted Therapeutics

Time: 2:30 pm
day: Day Two


  • Pursuing targeted approaches to drug discovery: unravelling the biological heterogeneity of ALS
  • Employing biomarkers to distinguish distinct patient subtypes and provide rational for individualized treatments
  • Developing targeted therapeutics for stratified patient populations